Non-Melanoma Skin Cancers
Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2024
2025
2026
DermBiontSM-020 1% Gel
Clinical Trials (1)
Total enrollment: 50 patients across 1 trials
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers
Start: Mar 2024Est. completion: Nov 202450 patients
Phase 2Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
15m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
15m ago
Office Administrator
SystImmune
15m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
25m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
29m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
29m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 50 patients
1 companies competing in this space